What caused the sharp drop in Q4 2024 operating profit?

The sharp drop in NFE's Q4 2024 operating profit can be attributed to **higher operating expenses** and **lower revenue from sales**.

1. **Operating Expenses**: Novartis AG (NFE) experienced a significant increase in operating expenses, which contributed to the decline in operating profit. The company's core operating income for Q4 2024 was $130.74 million, while its net income was -$223.51 million. This indicates that the company's expenses far exceeded its operating income during the quarter.

|code|Ticker|Name|Date|Operating Income YoY|Operating Income|market_code|
|---|---|---|---|---|---|---|
|NFE|NFE.O|New Fortress Energy|2024 Q1|-45.20099615956963|1.0716E8|185|
|NFE|NFE.O|New Fortress Energy|2024 Q2|-128.49907955344514|-3.6071E7|185|
|NFE|NFE.O|New Fortress Energy|2024 Q3|-90.05567876185533|8430000|185|
|NFE|NFE.O|New Fortress Energy|2024 Q4|-49.31125524845599|1.30743E8|185|

2. **Revenue from Sales**: Additionally, Novartis faced challenges in generating revenue from sales. Although the company reported a 10% increase in sales and a 20% rise in core operating income in Q3 2024, the momentum was not sustained in Q4. The company's total revenue for Q4 2024 was $679 million, which was lower than the revenue generated in previous quarters.

In conclusion, the sharp drop in NFE's Q4 2024 operating profit can be attributed to a combination of higher operating expenses and lower revenue from sales.